Search

everythinglearnresearchcommunity

for

Search:↓

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Herbal medicines can reduce the effectiveness of birth control pills.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Advanced human skin models improve drug development and could replace animal testing.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.

The conclusion is that measuring how drugs partition into artificial sebum is important for predicting their delivery into hair and sebaceous follicles, and it provides better information than traditional methods.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Bald men may have higher heart disease risk.

Some psychiatric medications can cause reversible hair loss.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

The metoprolol-spironolactone combination improves heart function in patients with coronary heart disease and heart failure.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Fasting may reduce chemotherapy side effects.

New methods are being developed to improve drug delivery to the brain.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Baldness may indicate higher heart disease risk in men.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Hair analysis can detect drug use but requires careful interpretation due to its complexity.